{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:17:42Z","timestamp":1788304662098,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Radiology Society of North America"},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EB035231"],"award-info":[{"award-number":["R01 EB035231"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Pennsylvania Abramson Cancer Center Sarcoma Pilot Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01069-x","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:44:28Z","timestamp":1781923468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prospective exploratory pilot study of 18\u00a0F-FMISO PET\/CT for assessing tumor hypoxia in soft tissue sarcomas"],"prefix":"10.1186","volume":"26","author":[{"given":"Ronnie","family":"Sebro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley M.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Karin Eisenger-Matheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Dulal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin R.","family":"Pantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Shabason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumarasen","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Pryma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Farwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob G.","family":"Dubroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Mankoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"1069_CR1","doi-asserted-by":"publisher","unstructured":"Ardakani AHG, Woollard A, Ware H, Gikas P. Soft tissue sarcoma: recognizing a rare disease. Cleve Clin J Med. 2022;89(2):73\u201380. https:\/\/doi.org\/10.3949\/ccjm.89a.21078. PMID: 35105695.","DOI":"10.3949\/ccjm.89a.21078"},{"key":"1069_CR2","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975\u20132017. Bethesda(MD): National Cancer Institute. Based on November 2019 SEER data submission, posted to the SEER website, April 2020. https:\/\/seer.cancer.gov\/csr\/1975_2017\/"},{"issue":"1114","key":"1069_CR3","doi-asserted-by":"publisher","first-page":"20190856","DOI":"10.1259\/bjr.20190856","volume":"93","author":"U Isidro","year":"2020","unstructured":"Isidro U, O\u2019Brien LM, Sebro R. Linear mixed-effects models for estimation of pulmonary metastasis growth rate: implications for CT surveillance in patients with sarcoma. Br J Radiol. 2020;93(1114):20190856. https:\/\/doi.org\/10.1259\/bjr.20190856. Epub 2020 Aug 26. PMID: 32559116; PMCID: PMC7548352.","journal-title":"Br J Radiol"},{"issue":"4","key":"1069_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.soc.2016.05.005","volume":"25","author":"CS Digesu","year":"2016","unstructured":"Digesu CS, Wiesel O, Vaporciyan AA, Colson YL. Management of Sarcoma Metastases to the Lung. Surg Oncol Clin N Am. 2016;25(4):721\u201333. https:\/\/doi.org\/10.1016\/j.soc.2016.05.005. PMID: 27591495; PMCID: PMC5028117.","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"1069_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/1541-7786.MCR-19-0877","volume":"18","author":"S Ye","year":"2020","unstructured":"Ye S, Liu Y, Fuller AM, Katti R, Ciotti GE, Chor S, Alam MZ, Devalaraja S, Lorent K, Weber K, Haldar M, Pack MA, Eisinger-Mathason TSK. TGF\u03b2 and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR). Mol Cancer Res. 2020;18(4):560\u201373. Epub 2020 Jan 27. PMID: 31988250; PMCID: PMC7127956.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1069_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbcan.2009.07.006","volume":"1796","author":"TR Geiger","year":"2009","unstructured":"Geiger TR, Peeper DS. Metastasis mechanisms. Biochim Biophys Acta. 2009;1796(2):293\u2013308. https:\/\/doi.org\/10.1016\/j.bbcan.2009.07.006. Epub 2009 Aug 14. PMID: 19683560.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1069_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.CD-13-0481","volume":"3","author":"S Vanharanta","year":"2013","unstructured":"Vanharanta S, Massagu\u00e9 J. Hypoxia signaling\u2013license to metastasize. Cancer Discov. 2013;3(10):1103\u20134. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0481. PMID: 24124230; PMCID: PMC3889127.","journal-title":"Cancer Discov"},{"key":"1069_CR8","doi-asserted-by":"publisher","unstructured":"Vaupel P, Kelleher DK, H\u00f6ckel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol. 2001;28(2 Suppl 8):29\u201335. https:\/\/doi.org\/10.1016\/s0093-77540190210-6. PMID: 11395850.","DOI":"10.1016\/s0093-77540190210-6"},{"issue":"2","key":"1069_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/cancers5020320","volume":"5","author":"N Sadri","year":"2013","unstructured":"Sadri N, Zhang PJ. Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas. Cancers (Basel). 2013;5(2):320\u201333. https:\/\/doi.org\/10.3390\/cancers5020320. PMID: 24216979; PMCID: PMC3730324.","journal-title":"Cancers (Basel)"},{"key":"1069_CR10","doi-asserted-by":"publisher","unstructured":"Vordermark D, Brown JM. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance? Strahlenther Onkol. 2003;179(12):801\u2009\u2013\u200911. https:\/\/doi.org\/10.1007\/s00066-003-1150-9. PMID: 14652668.","DOI":"10.1007\/s00066-003-1150-9"},{"key":"1069_CR11","unstructured":"Achermann R, Ohlerth S, Fidel J, Gardelle O, Gassmann M, Roos M, Saunders HM, Scheid A, Wergin M, Kaser-Hotz B. Ultrasound guided, pre-radiation oxygen measurements using polarographic oxygen needle electrodes in spontaneous canine soft tissue sarcomas. In Vivo. 2002 Nov-Dec;16(6):431-7. PMID: 12494886."},{"issue":"22","key":"1069_CR12","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.3390\/cancers14225675","volume":"14","author":"R Xu","year":"2022","unstructured":"Xu R, Qi L, Ren X, Zhang W, Li C, Liu Z, Tu C, Li Z. Integrated Analysis of TME and Hypoxia Identifies a Classifier to Predict Prognosis and Therapeutic Biomarkers in Soft Tissue Sarcomas. Cancers (Basel). 2022;14(22):5675. https:\/\/doi.org\/10.3390\/cancers14225675. PMID: 36428766; PMCID: PMC9688460.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1069_CR13","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1158\/2159-8290.CD-13-0118","volume":"3","author":"TS Eisinger-Mathason","year":"2013","unstructured":"Eisinger-Mathason TS, Zhang M, Qiu Q, Skuli N, Nakazawa MS, Karakasheva T, Mucaj V, Shay JE, Stangenberg L, Sadri N, Pur\u00e9 E, Yoon SS, Kirsch DG, Simon MC. Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. Cancer Discov. 2013;3(10):1190\u2013205. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0118. Epub 2013 Aug 1. PMID: 23906982; PMCID: PMC3822914.","journal-title":"Cancer Discov"},{"issue":"2","key":"1069_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1053\/j.semnuclmed.2014.10.006","volume":"45","author":"JG Rajendran","year":"2015","unstructured":"Rajendran JG, Krohn KA. F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy. Semin Nucl Med. 2015;45(2):151\u201362. https:\/\/doi.org\/10.1053\/j.semnuclmed.2014.10.006. PMID: 25704387; PMCID: PMC4339212.","journal-title":"Semin Nucl Med"},{"key":"1069_CR15","doi-asserted-by":"publisher","unstructured":"Zschaeck S, Steinbach J, Troost EG. FMISO as a biomarker for clinical radiation oncology. Recent Results Cancer Res. 2016;198:189\u2013201. https:\/\/doi.org\/10.1007\/978-3-662-49651-0_10. PMID: 27318688.","DOI":"10.1007\/978-3-662-49651-0_10"},{"key":"1069_CR16","doi-asserted-by":"publisher","unstructured":"Rajendran JG, Wilson DC, Conrad EU, Peterson LM, Bruckner JD, Rasey JS, Chin LK, Hofstrand PD, Grierson JR, Eary JF, Krohn KA. [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging. 2003;30(5):695\u2013704. https:\/\/doi.org\/10.1007\/s00259-002-1096-7. Epub 2003 Mar 11. PMID: 12632200.","DOI":"10.1007\/s00259-002-1096-7"},{"key":"1069_CR17","doi-asserted-by":"publisher","unstructured":"Liu RS, Chou TK, Chang CH, Wu CY, Chang CW, Chang TJ, Wang SJ, Lin WJ, Wang HE. Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model. Nucl Med Biol. 2009;36(3):305-12. https:\/\/doi.org\/10.1016\/j.nucmedbio.2008.12.011. PMID: 19324276.","DOI":"10.1016\/j.nucmedbio.2008.12.011"},{"issue":"2","key":"1069_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1053\/j.semnuclmed.2014.10.004","volume":"45","author":"CJ Koch","year":"2015","unstructured":"Koch CJ, Evans SM. Optimizing hypoxia detection and treatment strategies. Semin Nucl Med. 2015;45(2):163\u201376. https:\/\/doi.org\/10.1053\/j.semnuclmed.2014.10.004. PMID: 25704388; PMCID: PMC4365940.","journal-title":"Semin Nucl Med"},{"key":"1069_CR19","doi-asserted-by":"crossref","unstructured":"Potter C, Harris AL. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle. 2004;3(2):164-7. PMID: 14712082.","DOI":"10.4161\/cc.3.2.618"},{"key":"1069_CR20","doi-asserted-by":"publisher","unstructured":"DeBerardinis RJ, Chandel NS. We need to talk about the Warburg effect. Nat Metab. 2020;2(2):127\u2013129. https:\/\/doi.org\/10.1038\/s42255-020-0172-2. PMID: 32694689.","DOI":"10.1038\/s42255-020-0172-2"},{"issue":"1","key":"1069_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/metabo8010013","volume":"8","author":"C Ward","year":"2018","unstructured":"Ward C, Meehan J, Gray M, Kunkler IH, Langdon SP, Argyle DJ. Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness. Metabolites. 2018;8(1):13. https:\/\/doi.org\/10.3390\/metabo8010013. PMID: 29439394; PMCID: PMC5874614.","journal-title":"Metabolites"},{"key":"1069_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fcell.2018.00066","volume":"6","author":"Y Qi","year":"2018","unstructured":"Qi Y, Xu R. Roles of PLODs in Collagen Synthesis and Cancer Progression. Front Cell Dev Biol. 2018;6:66. https:\/\/doi.org\/10.3389\/fcell.2018.00066. PMID: 30003082; PMCID: PMC6031748.","journal-title":"Front Cell Dev Biol"},{"key":"1069_CR23","doi-asserted-by":"publisher","unstructured":"Rajendran JG, Mankoff DA, O\u2019Sullivan F, Peterson LM, Schwartz DL, Conrad EU, Spence AM, Muzi M, Farwell DG, Krohn KA. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res. 2004;10(7):2245-52. https:\/\/doi.org\/10.1158\/1078-0432.ccr-0688-3. PMID: 15073099.","DOI":"10.1158\/1078-0432.ccr-0688-3"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01069-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01069-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01069-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:58:59Z","timestamp":1788303539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01069-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01069-x","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the local Institutional Review Board (IRB) and the Food and Drug Administration (FDA) Investigational New Drug (IND) committee for the use of the investigational imaging agent\n                      18\n                      F-FMISO. Each subject provided signed informed consent at the time of entry into the study.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Signed informed consent from each participant was obtained.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"117"}}